Myriad Genetics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

SCHEDULE 13G/AOct. 27, 2026, 4:09 p.m. ETView on SEC.gov
8-KOct. 20, 2026, 8:36 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedMyriad Genetics to sell prenatal health testing business to Labcorp for $210 million cash plus inventory
8-KOct. 9, 2026, 4:16 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Financial statements and exhibits
4Sept. 22, 2026, 4:12 p.m. ETView on SEC.gov
4Sept. 18, 2026, 4:17 p.m. ETView on SEC.gov
4Sept. 17, 2026, 4:34 p.m. ETView on SEC.gov
8-KSept. 16, 2026, 8 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
4Sept. 8, 2026, 4:18 p.m. ETView on SEC.gov
SCHEDULE 13GSept. 4, 2026, 12:57 p.m. ETView on SEC.gov
4Aug. 17, 2026, 4:26 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 14, 2026, 4:59 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 14, 2026, 4:09 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 7, 2026, 10:09 a.m. ETView on SEC.gov
10-QJuly 31, 2026, 8:01 a.m. ETView on SEC.gov
8-KJuly 30, 2026, 4:07 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits